News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
58,927 Results
Type
Article (1513)
Company Profile (12)
Press Release (57402)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (27209)
Career Advice (47)
Deals (3906)
Drug Delivery (6)
Drug Development (5841)
Employer Resources (6)
FDA (1236)
Job Trends (1336)
News (36428)
Policy (1805)
Tag
Academia (107)
Accelerated approval (5)
Allergies (11)
Alliances (2055)
ALS (21)
Alzheimer's disease (134)
Antibody-drug conjugate (ADC) (45)
Approvals (1291)
Artificial intelligence (28)
Autoimmune disease (22)
Automation (3)
Bankruptcy (15)
Best Places to Work (1246)
Biosimilars (9)
Biotechnology (10)
Bladder cancer (38)
Brain cancer (7)
Breast cancer (95)
Cancer (578)
Cardiovascular disease (46)
Career advice (46)
Career pathing (3)
CAR-T (16)
CDC (2)
Cell therapy (59)
Cervical cancer (2)
Clinical research (5659)
Collaboration (93)
Compensation (47)
Complete response letters (4)
COVID-19 (133)
CRISPR (5)
C-suite (36)
Cystic fibrosis (9)
Data (907)
Depression (11)
Dermatology (9)
Diabetes (72)
Diagnostics (703)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (17)
Drug pricing (6)
Duchenne muscular dystrophy (13)
Earnings (26049)
Editorial (3)
Employer resources (5)
Events (5948)
Executive appointments (43)
FDA (1700)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (75)
Gene editing (12)
Generative AI (1)
Gene therapy (41)
GLP-1 (117)
Government (191)
Grass and pollen (1)
Guidances (243)
Healthcare (1836)
HIV (6)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (22)
Immuno-oncology (5)
Indications (18)
Infectious disease (163)
Inflammatory bowel disease (14)
Influenza (7)
Intellectual property (16)
Interviews (1)
IPO (2898)
IRA (2)
Job creations (155)
Job search strategy (41)
JPM (4)
Kidney cancer (3)
Labor market (9)
Layoffs (18)
Leadership (1)
Legal (357)
Liver cancer (12)
Longevity (2)
Lung cancer (102)
Lymphoma (52)
Machine learning (4)
Management (1)
Manufacturing (35)
MASH (29)
Medical device (1637)
Medtech (1644)
Mergers & acquisitions (1061)
Metabolic disorders (149)
mRNA (8)
Multiple sclerosis (13)
NASH (2)
Neurodegenerative disease (23)
Neuropsychiatric disorders (6)
Neuroscience (267)
NextGen: Class of 2026 (382)
Non-profit (322)
Now hiring (1)
Obesity (46)
Opinion (6)
Ovarian cancer (19)
Pain (19)
Pancreatic cancer (34)
Parkinson's disease (52)
Partnered (3)
Patents (32)
Patient recruitment (21)
Peanut (2)
People (1962)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase 1 (1388)
Phase 2 (2281)
Phase 3 (2388)
Pipeline (1751)
Policy (10)
Postmarket research (207)
Preclinical (413)
Press Release (9)
Prostate cancer (34)
Radiopharmaceuticals (20)
Rare diseases (62)
Real estate (207)
Recruiting (2)
Regulatory (1587)
Reports (11)
Research institute (88)
Resumes & cover letters (2)
Rett syndrome (2)
RNA editing (1)
RSV (10)
Schizophrenia (8)
Series A (5)
Series B (5)
Sickle cell disease (8)
Special edition (3)
Spinal muscular atrophy (18)
Sponsored (1)
Startups (124)
Stomach cancer (3)
Supply chain (10)
Tariffs (2)
The Weekly (1)
Vaccines (50)
Venture capital (3)
Weight loss (39)
Women's health (10)
Worklife (2)
Date
Last 7 days (95)
Last 30 days (360)
Last 365 days (3826)
2026 (972)
2025 (3846)
2024 (4264)
2023 (4867)
2022 (5335)
2021 (5823)
2020 (5154)
2019 (3858)
2018 (3079)
2017 (2894)
2016 (1949)
2015 (2511)
2014 (1668)
2013 (1163)
2012 (1239)
2011 (1400)
2010 (1356)
Location
Africa (45)
Alabama (6)
Arizona (18)
Asia (3101)
Australia (512)
California (1472)
Canada (391)
China (95)
Colorado (76)
Connecticut (65)
Delaware (71)
Europe (9164)
Florida (174)
Georgia (49)
Idaho (3)
Illinois (84)
India (2)
Indiana (112)
Japan (45)
Kansas (12)
Kentucky (5)
Louisiana (11)
Maine (21)
Maryland (227)
Massachusetts (934)
Michigan (34)
Minnesota (200)
Missouri (13)
Montana (2)
Nebraska (1)
Nevada (21)
New Hampshire (8)
New Jersey (503)
New York (355)
North Carolina (148)
Northern California (701)
Ohio (31)
Pennsylvania (344)
Puerto Rico (2)
Rhode Island (1)
South America (70)
South Carolina (3)
Southern California (664)
Tennessee (13)
Texas (249)
United States (5343)
Utah (41)
Virginia (10)
Washington D.C. (3)
Washington State (148)
Wisconsin (9)
58,927 Results for "76".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
April 2, 2026
·
4 min read
Press Releases
Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
January 7, 2026
·
5 min read
Press Releases
Oncology Clinical Trials Market Size Surges Toward USD 22.76 Billion as AI Transforms Recruitment and Trial Efficiency
December 9, 2025
·
1 min read
Press Releases
Pancreatic Cancer Diagnostic Market Size to Reach USD 9.76 Billion by 2034, Growing at a Stellar 13.8% CAGR
December 1, 2025
·
1 min read
Press Releases
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
November 10, 2025
·
6 min read
Press Releases
Akero Therapeutics to Present New Data from the Phase 2b SYMMETRY and HARMONY Studies of Efruxifermin at the 76th Annual AASLD The Liver Meeting® 2025
October 8, 2025
·
2 min read
Press Releases
Cell & Gene Therapy Contract Research Organizations Market Size to Surpass USD 13.76 Billion by 2034
July 30, 2025
·
1 min read
Press Releases
WINREVAIR™ (sotatercept-csrk) Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial
September 30, 2025
·
13 min read
Vaccines
CDC Highlights Efficacy of COVID-19 Shots in Kids Amid FDA Probe of Alleged Deaths
The 2024–2025 formulations of COVID-19 vaccines had an effectiveness rate of 76% at preventing emergency or urgent care visits in children aged 9 months through four years, according to a new report.
December 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
June 3, 2025
·
4 min read
1 of 5,893
Next
